USD 1.23 billion
Primary Cells Market Size, Share, Growth Analysis, By Type (Hematopoietic Cells), By Origin (Human Primary Cells, Animal Primary Cells), By Application (Research Applications), By End Use (Academic and Research Institutes), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2244 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
71
|Figures:
75
Primary Cells Market Insights
Primary Cells Market size was valued at USD 4.89 Billion in 2023 and is poised to grow from USD 5.53 Billion in 2024 to USD 14.83 Billion by 2032, growing at a CAGR of 13.1% during the forecast period (2025-2032).
The global primary cells market is experiencing increasing demand for cell-based research and the rising prevalence of chronic diseases. With an increasing understanding of the genetic and molecular basis of diseases, researchers are using primary cells to develop targeted therapies that are tailored to individual patients. This personalised approach has led to an upsurge in the demand for primary cells for disease modelling and drug screening, thereby driving market growth. The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has fueled the demand for primary cells. Researchers are using primary cells to study disease mechanisms, test novel therapeutics, and develop patient-specific treatment strategies. The ability of primary cells to mimic the complex physiological environment of tissues and organs has made them invaluable in understanding disease pathology and designing effective interventions.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Hematopoietic Cells
Fastest Growth
Dermatophytes cells
Growth Rate
10.4% CAGR
Global Primary Cells Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Primary Cells Market Segmental Analysis
Global Primary Cells Market is segmented by type, origin, application, end use and region. Based on type, the market is segmented into hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells and other cells. Based on origin, the market is segmented into human primary cells and animal primary cells. Based on application, the market is segmented into research applications and therapeutic applications. Based on end use, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories and cell banks and tissue banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Type
Hematopoietic Cells, which include cells like red blood cells, white blood cells, and platelets, are the most dominant type in the global primary cells market. These cells are derived from the bone marrow or peripheral blood and have various applications in research, drug discovery, and regenerative medicine. Hematopoietic cells are extensively studied and utilised due to their critical role in immune response and blood-related disorders.
On the other hand, the fastest-growing type in the global primary cells market is Dermatophytes. Dermatophytes are specialised cells derived from the skin tissue. They have gained significant attention in recent years, driven by increasing research and development activities in dermatology, wound healing, and cosmetic testing. Dermatophytes play a vital role in studying skin diseases, drug testing for dermatological conditions, and understanding the mechanisms of skin regeneration.
Analysis by Application
Cancer Research holds a significant market share and is the leading application of primary cells. The use of primary cells in cancer research allows for the study of tumour biology, drug discovery, and personalised medicine. Primary cancer cells obtained directly from patient samples closely resemble the characteristics and behaviour of tumours in vivo, making them invaluable for studying cancer cell biology, drug response, and developing targeted therapies. The importance of cancer research and the continuous efforts to improve cancer treatment contribute to the dominance of this application in the primary cells market.
On the other hand, Regenerative Medicine is experiencing rapid growth in the market. Regenerative Medicine focuses on the development of therapies that can repair, replace, or regenerate damaged or diseased tissues and organs. Primary cells play a vital role in regenerative medicine by providing a reliable and biologically relevant cellular model for tissue engineering, cell-based therapies, and organ transplantation. The increasing research activities, technological advancements, and the potential of regenerative medicine to revolutionise healthcare have propelled the growth of primary cells in this application.
Global Primary Cells Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Primary Cells Market Regional Insights
North America holds a significant share in the pacemaker market due to several factors. The region has well-established healthcare infrastructure, advanced medical technologies, and a high prevalence of cardiovascular diseases. Additionally, factors such as increasing healthcare expenditure, favourable reimbursement policies, and a strong presence of major pacemaker manufacturers contribute to the dominance of North America in the market. The US, in particular, has a large patient pool, sophisticated healthcare systems, and a high adoption rate of pacemakers, further solidifying the region's dominant position.
On the other hand, the Asia Pacific region is experiencing the fastest growth in the pacemaker market. The rising prevalence of cardiovascular diseases, increasing healthcare spending, and improving healthcare infrastructure are driving the demand for pacemakers in this region. Countries like China and India, with their large population base and growing middle-class population, are witnessing significant market growth. Moreover, increased awareness about cardiac health, advancements in medical technology, and the availability of cost-effective pacemakers contribute to the rapid growth of the Asia Pacific region.
Global Primary Cells By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Primary Cells Market Dynamics
Primary Cells Market Drivers
Advancements in Tissue Engineering and Regenerative Medicine
- Advancements in Tissue Engineering and Regenerative Medicine have significantly progressed in recent years, driving the demand for primary cells in the development of engineered tissues and organs for transplantation purposes. This increasing focus on regenerative medicine and tissue engineering has propelled the growth of the primary cells market.
Primary Cells Market Restraints
Short Shelf Life
- Primary cells face the challenge of having a short shelf life compared to immortalised cell lines. They undergo senescence or lose their specific characteristics over time, leading to reduced functionality. This limitation in their lifespan poses challenges in terms of storage, distribution, and use in long-term experiments, which can impact their market potential.
Request Free Customization of this report to help us to meet your business objectives.
Primary Cells Market Competitive Landscape
Market players engage in rigorous research and development efforts to expand their product portfolios, improve cell sourcing methods, and enhance the quality of primary cells. This focus on innovation and development of novel primary cell lines aims to cater to the diverse needs of researchers and facilitate advancements in various fields, such as cancer research, regenerative medicine, and drug discovery.
Top Player’s Company Profiles
- Thermo Fisher Scientific Inc.
- Lonza Group AG
- Merck KGaA
- PromoCell GmbH
- Cell Biologics Inc.
- ZenBio Inc.
- STEMCELL Technologies Inc.
- AllCells LLC
- American Type Culture Collection (ATCC)
- Axol Bioscience Ltd.
- Creative Bioarray
- ScienCell Research Laboratories Inc.
- BioIVT
- Corning Incorporated
- Bio-Techne Corporation
- Charles River Laboratories International Inc.
- Cureline Inc.
- Cell Applications Inc.
- iXCells Biotechnologies
- Neuromics
Recent Developments
- In May 2023, Lonza announced that it had expanded its primary cell manufacturing capacity in Singapore. The expansion will increase the company's capacity to produce primary cells by 50%.
- In April 2023, Thermo Fisher Scientific announced that it had acquired ATCC, a leading provider of primary cells. The acquisition will give Thermo Fisher Scientific a strong portfolio of primary cells for research and development.
- In March 2023, STEMCELL Technologies announced that it has launched a new line of primary cells, the STEMCELL Affinity™ Primary Cell Line. The STEMCELL Affinity™ Primary Cell Line is a line of primary cells that are optimised for use in research.
- In February 2023, Cell Applications announced that it had launched a new line of primary cells, the Cell Applications™ Primary Cell Line. The Cell Applications™ Primary Cell Line is a line of primary cells that are optimised for use in drug discovery.
- In January 2023, PromoCell announced that it had launched a new line of primary cells, the PromoCell™ Primary Cell Line. The PromoCell™ Primary Cell Line is a line of primary cells that are optimised for use in cell therapy.
Primary Cells Key Market Trends
- Demand for Personalised Medicine: Personalised medicine focuses on tailoring medical treatments to individual patients based on their specific genetic makeup, disease characteristics, and other factors. Primary cells play a crucial role in this approach as they provide a more accurate representation of human biology compared to cell lines or animal models. Researchers and pharmaceutical companies are increasingly using primary cells to develop personalised therapies and conduct preclinical studies. The ability to study patient-specific responses and evaluate drug efficacy and safety in a more relevant cellular context has propelled the adoption of primary cells in drug discovery and development.
Primary Cells Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to the global primary cells market analysis, the increasing demand for reliable cell-based models and the growing focus on personalised medicine are driving market growth. Primary cells, derived directly from living tissues or organs, offer physiological relevance and accurately represent in vivo conditions for drug discovery, toxicity testing, and disease modelling. The market is witnessing significant adoption across various industries, including pharmaceuticals, biotechnology, and research laboratories. Regional analysis reveals that North America dominates the primary cell market due to its well-established healthcare infrastructure, substantial investments in research and development, and the presence of key market players. Additionally, Europe holds a significant market share, driven by the increasing demand for personalised medicine and advancements in regenerative medicine. The Asia Pacific region is expected to witness substantial growth, fueled by factors such as the rising geriatric population, increasing prevalence of chronic diseases, and advancements in healthcare infrastructure. The primary cells market offers growth opportunities due to the expanding applications of primary cells in disease modelling, drug discovery, and regenerative medicine. Factors such as the need for more accurate and reliable preclinical models, the emergence of 3D cell culture technologies, and the growing investments in stem cell research contribute to market growth.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.23 billion |
| Market size value in 2031 | USD 3.0 billion |
| Growth Rate | 10.4% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Primary Cells Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Primary Cells Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Primary Cells Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Primary Cells Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Primary Cells Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Primary Cells Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
